Axcelis Technologies Inc (ACLS)

Sep 26, 2026

Axcelis Technologies, Inc. saw its shares surge by 5.1% on Friday, closing at $122.02, as the semiconductor equipment sector experienced a broad rally. This rally, which also saw gains in other sector peers like AXT, Aehr Test Systems, and Cohu, appears driven by renewed investor optimism or tactical positioning rather than company-specific news. Investors are advised to monitor whether this sector strength continues into the next trading week and if any industry commentary validates the current optimism.

Sep 22, 2026

Axcelis Technologies (ACLS) shares saw an uptick after announcing plans for a new $35 million ion implantation manufacturing facility in Korea, despite recent short-term dips. The stock's valuation is a point of contention, with some analysts seeing it as 30% undervalued at $161, while a Simply Wall St DCF model suggests it is expensive at $10.79 per share compared to its current price of $113.15. Investors are left to reconcile these conflicting valuations.

Sep 16, 2026

Christopher Tatnall, EVP of Global Customer Operations at Axcelis Technologies, forfeited 136 shares of common stock valued at $105.04 per share. This forfeiture was to cover tax obligations related to the vesting of restricted stock units granted in September 2023. Following this transaction, Tatnall beneficially owns 27,491 shares, with 20,590 of these still subject to forfeiture upon vesting of RSUs under the 2012 Equity Incentive Plan.

Sep 16, 2026

Axcelis Technologies (NASDAQ: ACLS) has outperformed the market over the last five years, achieving an average annual return of 16.86%, which is 5.42% higher than the market's performance. An initial investment of $100 in ACLS five years ago would now be worth $215.50. This demonstrates the significant impact of compounded returns on investment growth over time.